Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Other Non-Current Assets (2018 - 2025)

Addex Therapeutics' Other Non-Current Assets history spans 8 years, with the latest figure at $8865.8 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 9.56% to $8865.8 in Q4 2025 year-over-year; TTM through Dec 2025 was $8865.8, a 9.56% increase, with the full-year FY2025 number at $8546.6, up 5.61% from a year prior.
  • Other Non-Current Assets came in at $8865.8 for Q4 2025, up from $8092.2 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $904951.5 in Q1 2024, with the low at $8092.2 in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $183732.9 across 5 years, with a median of $58843.3 in 2022.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 86.79% in 2024 and later grew 9.56% in 2025.
  • Year by year, Other Non-Current Assets stood at $62801.3 in 2021, then dropped by 10.16% to $56421.7 in 2022, then rose by 8.58% to $61265.0 in 2023, then crashed by 86.79% to $8092.2 in 2024, then grew by 9.56% to $8865.8 in 2025.
  • Business Quant data shows Other Non-Current Assets for ADXN at $8865.8 in Q4 2025, $8092.2 in Q4 2024, and $904951.5 in Q1 2024.